ripretinib

Ligand id: 9175

Name: ripretinib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 7
Topological polar surface area 86.36
Molecular weight 509.09
XLogP 5.11
No. Lipinski's rules broken 1

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
IUPAC Name
1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea
Synonyms
DCC-2618
Comments
DCC-2618 is an orally bioavailable, preclinical pan-KIT kinase inhibitor being developed by Dicephera Pharmaceuticals for potential oncology use. It is claimed in patent WO2010051373 [1] as Example 39. Note that (as of June 2018) there are different structures associated with DCC-2618 in PubChem but our entry agrees with the USAN specification. Note that some SIDs are linked to the incorrect structure with PubChem CID 46208890.
Database Links
CAS Registry No. 1442472-39-0 (source: PubChem)
GtoPdb PubChem SID 315661258
PubChem CID 71584930
Search Google for chemical match using the InChIKey CEFJVGZHQAGLHS-UHFFFAOYSA-N
Search Google for chemicals with the same backbone CEFJVGZHQAGLHS
Search UniChem for chemical match using the InChIKey CEFJVGZHQAGLHS-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone CEFJVGZHQAGLHS